Search filters

List of works by Richard A Feelders

ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase

scientific article published on 13 September 2013

Advances in the medical treatment of Cushing's syndrome

scientific article published on 20 July 2018

Comorbidities in Cushing's disease

scientific article

Cushing's syndrome

scientific article (publication date: 29 August 2015)

Cushing's syndrome: epidemiology and developments in disease management

scientific article published on 17 April 2015

Diagnostic imaging of dopamine receptors in pituitary adenomas

scientific article published on April 2007

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

scientific article

Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors

scientific article published on 01 June 2019

Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function

scientific article published on 27 May 2009

Endoscopic bilateral adrenalectomy in patients with ectopic Cushing’s syndrome

scientific article published on November 2, 2011

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

scientific article published on 16 January 2008

Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation

scientific article

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.

scientific article

Melanocortin 2 Receptor-Associated Protein (MRAP) and MRAP2 in Human Adrenocortical Tissues: Regulation of Expression and Association with ACTH Responsiveness

scientific article published on March 14, 2012

Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion

scientific article published on 16 November 2011

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate

scientific article published on 13 August 2015

Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

scientific article published on 20 March 2017

Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN.

scientific article published on 12 February 2018

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

scientific article

Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome

scientific article

Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.

scientific article

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors

scientific article

Somatostatin receptor imaging for neuroendocrine tumors

scientific article published on January 2006

Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.

scientific article published in January 2019

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

scientific article published in May 2008